Activation of PKC in the kidney by hyperglycemia reduces GLP-1 signaling while enhancing angiotensin II and nuclear factor-κB (NF-κB) signaling pathways with subsequent development of glomerular endothelial dysfunction [12]. This evidence concerns the gene PRRT2 and Hyperglycemia.